Humacyte Inc (HUMA)
4.40
+0.48
(+12.24%)
USD |
NASDAQ |
May 01, 16:00
4.39
-0.01
(-0.23%)
After-Hours: 20:00
Humacyte Total Assets (Quarterly): 128.22M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 128.22M |
| September 30, 2023 | 149.38M |
| June 30, 2023 | 168.11M |
| March 31, 2023 | 182.98M |
| December 31, 2022 | 204.30M |
| September 30, 2022 | 226.22M |
| Date | Value |
|---|---|
| June 30, 2022 | 246.36M |
| March 31, 2022 | 264.47M |
| December 31, 2021 | 286.53M |
| September 30, 2021 | 303.36M |
| December 31, 2020 | 106.69M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
106.69M
Minimum
Dec 2020
303.36M
Maximum
Sep 2021
206.06M
Average
204.30M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Adial Pharmaceuticals Inc | 4.737M |
| Gritstone Bio Inc | 177.77M |
| Precision BioSciences Inc | 159.78M |
| Puma Biotechnology Inc | 230.53M |
| Revance Therapeutics Inc | 478.45M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 114.68M |
| Shareholders Equity (Quarterly) | 13.55M |